Business / Finance RSS Feed - Business / Finance

Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics Biotech Inc. announced today that it has entered into an "at-the-market" (ATM) equity distribution agreement with Canaccord Genuity Inc. acting as sole agent. [More]
Aseptika selected for Discovery Start-Ups 2014 award

Aseptika selected for Discovery Start-Ups 2014 award

Aseptika Limited was selected as one of five winners out of the eighteen strong field of UK start-up companies pitching for the winning prizes at the Discovery Start-Ups 2014 event held on Wednesday, 22nd October at Deloitte’s in London. [More]
The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy. [More]
Global hospital sector investing in new equipment to drive efficiency gains & profitability, GE Capital research finds

Global hospital sector investing in new equipment to drive efficiency gains & profitability, GE Capital research finds

Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital’s inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets. [More]
Telstra launches vision for a more connected healthcare system

Telstra launches vision for a more connected healthcare system

Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia’s leading provider of integrated eHealth solutions. [More]
Crown Bioscience announces U.S. expansion with new translational oncology center

Crown Bioscience announces U.S. expansion with new translational oncology center

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced the opening of the Crown Bioscience US Research Center to be located at the David H. Murdock Research Institute (DHMRI), in Kannapolis, N.C. The new center, which will open in the 3rd quarter of 2014, represents significant U.S. market expansion for Crown. [More]
YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist -- PAS-YNSα8 -- which has been jointly developed by scientists at the Weizmann Institute and XL-protein. [More]

Marken to expand global cold chain network to meet demand for packaging solutions

Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions. [More]
SensorUp, Vivametrica partner to standardize wearable device data for healthcare environments

SensorUp, Vivametrica partner to standardize wearable device data for healthcare environments

The exponential growth in the number of people tracking their health through activity monitors and biosensor devices is driving the need for industry standards. [More]
Directed Genomics, New England Biolabs to develop new technologies for NGS

Directed Genomics, New England Biolabs to develop new technologies for NGS

New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new technologies for next generation sequencing (NGS), including target enrichment. [More]
NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery. [More]
AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois. [More]
Twinlab Consolidated Holdings to expand contract manufacturing business

Twinlab Consolidated Holdings to expand contract manufacturing business

Twinlab Consolidated Holdings, Inc. ("TLCC" or the "Company") announced today that it expects to add more than 20 new American jobs to support its expanding contract manufacturing business. [More]

HealthCare Royalty Partners closes $1.5B for HealthCare Royalty Partners III, L.P., affiliated entities

HealthCare Royalty Partners ("HC Royalty"), a global healthcare investment firm, today announced the closing on $1.5 billion for HealthCare Royalty Partners III, L.P. ("Fund III") and affiliated entities. [More]

Henry Schein invests in Iwase Dental Supply

Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has invested in Iwase Dental Supply, Inc., a leading full-service provider of dental consumables, implants and equipment in Japan. [More]

Altamont announces majority equity investment in Legacy ER & Urgent Care

Altamont Capital Partners (Altamont) and Kingfish Group (Kingfish) today announced a majority equity investment into Legacy ER & Urgent Care (Legacy), a leading operator of hybrid standalone ER and urgent care clinics. [More]

SynGen announces relocation of corporate headquarters

SynGen, Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has moved its corporate headquarters to a new location in Sacramento, California. The headquarter’s new address is 100 Howe Avenue, Suite 185N, Sacramento, CA 95825-8219. All other contact information, including phone numbers, remains the same. [More]
Emo Capital, I-Omni partner to develop new compression wear clothing line

Emo Capital, I-Omni partner to develop new compression wear clothing line

Emo Capital Corp. is pleased to announce that a memorandum of understanding (MOU) was signed with I-Omni Co. Ltd. of Seoul, South Korea . [More]
Highland completes US$25 million offering of Class A Common Shares

Highland completes US$25 million offering of Class A Common Shares

Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success. [More]

Danaher's net earnings increase 13% to $680.6 million in third quarter 2014

Danaher Corporation today announced results for the third quarter of 2014. [More]